We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgery for Sleep Apnea Found to Equal CPAP Benefits

By HospiMedica International staff writers
Posted on 03 Sep 2009
Reconstructive surgery of the upper airway for obstructive sleep apnea (OSA) holds the same quality-of-life (QOL) benefits as continuous positive airway pressure (CPAP), according to a new study.

Researchers from Memorial Hospital (Adelaide, Australia) conducted a consecutive cohort study of 166 adult patients with moderate-severe obstructive sleep apnea (OSA), of whom 77 underwent upper airway surgery, and 89 others were treated with CPAP therapy. More...
Glasgow Benefit Inventory (GBI), change in snoring status and Epworth Sleepiness Scale (ESS), subjective CPAP compliance, and side effects in both groups were measured at mean 3.68 years (±0.48 years) after commencement of therapy.

The researchers found no significant difference between surgical outcomes for GBI, snoring, or ESS and CPAP controls. Among patients with moderate-to-severe OSA, those treated through upper airway surgery experienced the same level of long-term QOL improvement as their peers who were treated with CPAP therapy; among the QOL benefits were improvements in snoring, sleepiness, and neurocognitive impairment. In contrast, those patients who were prescribed, but did not adequately use CPAP, had minimal QOL improvement. CPAP side effects, reported in 26% of the patients, significantly reduced the QOL benefit of treatment, independent of compliance. Surgical complications (occurring in 44% of the patients) did not affect QOL treatment benefit. The study was published in the August 2009 issue of the journal Otolaryngology-Head and Neck Surgery.

"CPAP therapy is a highly effective means for treating obstructive sleep apnea, but because it involves a mask and set of hoses, it can be frustrating and uncomfortable for some patients, and compliance may be short-lived,” concluded lead author Sam Robinson, MB, BS, and colleagues. "Patients with poor CPAP compliance and/or significant side effects of CPAP therapy should be evaluated for contemporary upper airway reconstructive surgery.”

OSA is a common sleep apnea caused by obstruction of the airway, characterized by pauses in breathing during sleep. Breathing is interrupted by a physical block to airflow, despite the effort to breathe. In adults, the most typical individual with OSA syndrome suffers from obesity, with particular heaviness at the face and neck.

Related Links:
Memorial Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.